RALOXIFEN ARENA 60mg tablets medication leaflet

G03XC01 raloxifene • Genito urinary system and sex hormones | Other sex hormones and modulators of the genital system | Selective estrogen receptor modulators

Raloxifene is a medication used for the prevention and treatment of osteoporosis in postmenopausal women. It belongs to the class of selective estrogen receptor modulators (SERMs) and works by maintaining bone density and reducing the risk of fractures.

The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to follow the prescribed dosage and combine the treatment with adequate calcium and vitamin D intake.

Side effects may include hot flashes, muscle cramps, swelling, or flu-like symptoms. In rare cases, severe adverse effects such as deep vein thrombosis or pulmonary embolism may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as clotting disorders, to ensure the safe use of raloxifene.

General data about RALOXIFEN ARENA 60mg

Substance: raloxifene

Date of last drug list: 01-06-2025

Commercial code: W62041003

Concentration: 60mg

Pharmaceutical form: tablets

Quantity: 84

Product type: generic

Price: 136.71 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: PHARAMATHEN S.A. - GRECIA

Holder: ARENA GROUP S.A. - ROMANIA

Number: 8031/2015/03

Shelf life: 3 years

Other substances similar to raloxifene

Compensation lists for RALOXIFEN ARENA 60mg ARENA

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

136.71 RON

68.36 RON

68.36 RON

NHP 7 (C2) - Endocrine diseases

Price

Copayment

Patient

136.71 RON

136.71 RON

0.00 RON